These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
379 related articles for article (PubMed ID: 30340327)
21. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery. Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838 [TBL] [Abstract][Full Text] [Related]
22. Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate. Mahmoudian M; Maleki Dizaj S; Salatin S; Löbenberg R; Saadat M; Islambulchilar Z; Valizadeh H; Zakeri-Milani P Expert Opin Drug Deliv; 2021 Nov; 18(11):1707-1722. PubMed ID: 34553650 [TBL] [Abstract][Full Text] [Related]
23. Protein-lipid nanohybrids as emerging platforms for drug and gene delivery: Challenges and outcomes. Gaber M; Medhat W; Hany M; Saher N; Fang JY; Elzoghby A J Control Release; 2017 May; 254():75-91. PubMed ID: 28365294 [TBL] [Abstract][Full Text] [Related]
24. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs). Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539 [TBL] [Abstract][Full Text] [Related]
25. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery. Rajpoot K Curr Pharm Des; 2019; 25(37):3943-3959. PubMed ID: 31481000 [TBL] [Abstract][Full Text] [Related]
26. Nebulized solid lipid nanoparticles for the potential treatment of pulmonary hypertension via targeted delivery of phosphodiesterase-5-inhibitor. Makled S; Nafee N; Boraie N Int J Pharm; 2017 Jan; 517(1-2):312-321. PubMed ID: 27979766 [TBL] [Abstract][Full Text] [Related]
27. Solid Lipid Nanoparticles as an Innovative Lipidic Drug Delivery System. Waghmare S; Palekar R; Potey L; Khedekar P; Sabale P; Sabale V Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38317470 [TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration. Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506 [TBL] [Abstract][Full Text] [Related]
29. Recent advances in drug delivery applications of cubosomes, hexosomes, and solid lipid nanoparticles. Yaghmur A; Mu H Acta Pharm Sin B; 2021 Apr; 11(4):871-885. PubMed ID: 33996404 [TBL] [Abstract][Full Text] [Related]
30. Development of solid lipid nanoparticles-loaded drugs in parasitic diseases. Nemati S; Mottaghi M; Karami P; Mirjalali H Discov Nano; 2024 Jan; 19(1):7. PubMed ID: 38175309 [TBL] [Abstract][Full Text] [Related]
31. Formulating SLN and NLC as Innovative Drug Delivery Systems for Non-Invasive Routes of Drug Administration. Fonseca-Santos B; Silva PB; Rigon RB; Sato MR; Chorilli M Curr Med Chem; 2020; 27(22):3623-3656. PubMed ID: 31232233 [TBL] [Abstract][Full Text] [Related]
32. Pickering nano-emulsions stabilized by solid lipid nanoparticles as a temperature sensitive drug delivery system. Dieng SM; Anton N; Bouriat P; Thioune O; Sy PM; Massaddeq N; Enharrar S; Diarra M; Vandamme T Soft Matter; 2019 Oct; 15(40):8164-8174. PubMed ID: 31593197 [TBL] [Abstract][Full Text] [Related]
33. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate. Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354 [TBL] [Abstract][Full Text] [Related]
34. Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique. Arduino I; Liu Z; Rahikkala A; Figueiredo P; Correia A; Cutrignelli A; Denora N; Santos HA Acta Biomater; 2021 Feb; 121():566-578. PubMed ID: 33326887 [TBL] [Abstract][Full Text] [Related]
35. Dermal Delivery of Lipid Nanoparticles: Effects on Skin and Assessment of Absorption and Safety. Pinto F; Fonseca LP; de Barros DPC Adv Exp Med Biol; 2022; 1357():83-114. PubMed ID: 35583641 [TBL] [Abstract][Full Text] [Related]
36. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems. Madkhali OA Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643 [TBL] [Abstract][Full Text] [Related]
37. Interfacial and colloidal characterization of oil-in-water emulsions stabilized by interface-tunable solid lipid nanoparticles. Lim H; Jo M; Ban C; Choi YJ Food Chem; 2020 Feb; 306():125619. PubMed ID: 31606630 [TBL] [Abstract][Full Text] [Related]
38. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies. Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845 [TBL] [Abstract][Full Text] [Related]
39. Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting. Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Patel RJ; Ajazuddin ; Ravichandiran V; Murty US; Alexander A J Control Release; 2020 May; 321():372-415. PubMed ID: 32061621 [TBL] [Abstract][Full Text] [Related]